Position in AKTS
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$98,953,158
+$42,396,643 QoQ
Shares Held
3,070,219
-2.9% QoQ
Ownership
5.52%
of shares outstanding
% of Portfolio
15.07%
of 13F equity value
Holder Rank
#3
of 113 holders
Holding Since
Mar 2026
2 quarters on record
Common Shares in AKTS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Blue Owl Capital Holdings LP holds $278,984,828 across 30 Biotechnology names. AKTS ranks #1 (35.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AKTS |
Aktis Oncology, Inc.
This page
|
3,070,219 | $98,953,158 | |
| 2 | CGEM |
Cullinan Therapeutics, Inc.
|
1,539,764 | $28,039,102 | |
| 3 | LRMR |
Larimar Therapeutics, Inc.
|
9,163,157 | $27,947,628 | |
| 4 | MPLT |
MapLight Therapeutics, Inc.
|
729,929 | $26,160,655 | |
| 5 | EYPT |
EyePoint, Inc.
|
762,594 | $10,905,094 | |
| 6 | SGMT |
Sagimet Biosciences Inc.
|
1,260,544 | $9,744,005 | |
| 7 | CRVS |
Corvus Pharmaceuticals, Inc.
|
608,600 | $9,092,484 | |
| 8 | ARTV |
Artiva Biotherapeutics, Inc.
|
874,542 | $8,483,057 |
All Filings in AKTS
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $98,953,158 | 3,070,219 | Shares | Defined | 2026-08-11 | |
| 2026-03-31 | $56,556,515 | 3,161,348 | Shares | Defined | 2026-05-14 | |
| 2026-03-31 | $56,556,515 | 3,161,348 | Shares | Sole | 2026-05-14 | |
| No filing history on record for this holder in this stock. | ||||||